Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Development of the Lymphatic System01:15

Development of the Lymphatic System

774
The development of lymphatic tissues and vessels in embryonic life begins around the fifth week. These structures originate from the mesoderm layer, with lymph sacs emerging from developing veins.
The first lymph sacs to form are the paired jugular lymph sacs located at the junction of the internal jugular and subclavian veins. From these sacs, lymphatic capillary plexuses extend to the thorax, upper limbs, neck, and head, eventually forming lymphatic vessels. Each jugular lymph sac maintains a...
774
Lymphatic Vessels and Lymph Transport01:16

Lymphatic Vessels and Lymph Transport

3.7K
Lymphatic vessels, known as lymphatics, are crucial in transporting lymph from peripheral tissues to our venous system. This process begins with lymph entering through tiny capillaries that branch through tissues. These capillaries have unique features such as larger diameters, thinner walls, and a distinctive one-way valve system formed by overlapping endothelial cells.
This one-way system allows fluids, solutes, and even pathogens to enter but prevents their return to the intercellular...
3.7K
Secondary Lymphoid Organs01:15

Secondary Lymphoid Organs

1.6K
Secondary organs, including lymph nodes, the spleen, and mucosa-associated lymphoid tissue (MALT), work harmoniously to protect us from disease and infection.
The spleen is a vital organ in the lymphatic system, nestled in the upper left side of the abdomen. It is composed of two primary regions: the red pulp and the white pulp, each having distinct functions. The red pulp performs a significant role in blood filtration. It efficiently purges the blood of old or damaged red blood cells and...
1.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Ten-year follow-up of monozygotic twin sisters with TSC-LAM: A rare case report.

Respiratory medicine case reports·2026
Same author

Cladribine for pulmonary Langerhans cell histiocytosis: first prospective evidence and a new therapeutic horizon.

The European respiratory journal·2026
Same author

Prognostic Role of Immunonutritional Indices in Elderly Patients with HFpEF: Long-Term Follow-Up of the CONUT, PNI, and CALLy Scores.

Journal of clinical medicine·2026
Same author

Identification of a Cut-Off Value to Identify Sarcopenia Through Pectoralis Muscle Area in Fibrotic ILDs: An International Study.

Archivos de bronconeumologia·2026
Same author

Interstitial lung disease in ANCA-associated vasculitis: comment on the article by Chalkia et al.

Arthritis & rheumatology (Hoboken, N.J.)·2026
Same author

Access to lymphangioleiomyomatosis care across Europe: an ERN-LUNG survey of clinical practice, and the case for a European registry and trial network.

ERJ open research·2026

Related Experiment Video

Updated: Jul 16, 2025

Isolation of Human Lymphatic Endothelial Cells by Multi-parameter Fluorescence-activated Cell Sorting
07:36

Isolation of Human Lymphatic Endothelial Cells by Multi-parameter Fluorescence-activated Cell Sorting

Published on: May 1, 2015

14.4K

Lymphangioleiomyomatosis.

Davide Elia1, Roberto Cassandro1, Antonella Caminati1

  • 1UO di Pneumologia e Terapia Semi-Intensiva Respiratoria - Servizio di Fisiopatologia Respiratoria ed Emodinamica Polmonare, MultiMedica IRCCS, Via San Vittore 12, 20123 Milan, Italy.

Presse Medicale (Paris, France : 1983)
|September 11, 2023
PubMed
Summary

Lymphangioleiomyomatosis (LAM) is a rare neoplastic disease affecting women of childbearing age. Recent advances improve understanding of LAM pathogenesis, leading to better biomarkers, treatments, and disease management.

More Related Videos

Sentinel Lymph Node Mapping and Biopsy for Endometrial Cancer at Early Stage with Laparoscopy
05:52

Sentinel Lymph Node Mapping and Biopsy for Endometrial Cancer at Early Stage with Laparoscopy

Published on: August 19, 2021

11.5K
Author Spotlight: Magnetic Bead-Based Isolation of Murine Dermal Lymphatic Endothelial Cells
05:52

Author Spotlight: Magnetic Bead-Based Isolation of Murine Dermal Lymphatic Endothelial Cells

Published on: July 21, 2023

1.7K

Related Experiment Videos

Last Updated: Jul 16, 2025

Isolation of Human Lymphatic Endothelial Cells by Multi-parameter Fluorescence-activated Cell Sorting
07:36

Isolation of Human Lymphatic Endothelial Cells by Multi-parameter Fluorescence-activated Cell Sorting

Published on: May 1, 2015

14.4K
Sentinel Lymph Node Mapping and Biopsy for Endometrial Cancer at Early Stage with Laparoscopy
05:52

Sentinel Lymph Node Mapping and Biopsy for Endometrial Cancer at Early Stage with Laparoscopy

Published on: August 19, 2021

11.5K
Author Spotlight: Magnetic Bead-Based Isolation of Murine Dermal Lymphatic Endothelial Cells
05:52

Author Spotlight: Magnetic Bead-Based Isolation of Murine Dermal Lymphatic Endothelial Cells

Published on: July 21, 2023

1.7K

Area of Science:

  • Oncology
  • Pulmonology
  • Genetics

Background:

  • Lymphangioleiomyomatosis (LAM) is an ultra-rare neoplastic cystic disease, classified as a perivascular epithelioid cell tumor (PEComa).
  • LAM affects primarily women of childbearing age and can occur sporadically or in association with tuberous sclerosis complex.
  • Common symptoms include dyspnea and spontaneous pneumothorax, with extrathoracic manifestations like renal angiomyolipomas.

Purpose of the Study:

  • To summarize recent advances in understanding the molecular pathogenesis of LAM.
  • To highlight improvements in the research of novel biomarkers for LAM.
  • To discuss advancements in treatment strategies and disease management for LAM patients.

Main Methods:

  • Review of recent scientific literature focusing on LAM pathogenesis.
  • Analysis of molecular mechanisms underlying LAM development.
  • Evaluation of progress in biomarker discovery and therapeutic development.

Main Results:

  • Significant progress has been made in elucidating the molecular pathways involved in LAM.
  • Identification of potential novel biomarkers for earlier diagnosis and monitoring of LAM.
  • Development of improved therapeutic approaches and patient management strategies.

Conclusions:

  • Understanding LAM pathogenesis has led to significant improvements in research and clinical practice.
  • Continued research into molecular mechanisms is crucial for developing more effective treatments.
  • Enhanced management strategies are improving outcomes for patients with this rare disease.